Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Novartis
Daiichi Sankyo
Argus Health
Julphar
Dow
McKinsey
US Army
Boehringer Ingelheim
UBS

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,110,921

« Back to Dashboard

Summary for Patent: 6,110,921

Title: Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
Abstract:The invention relates to a method of treating psychotic disorders comprising a biodegradable and biocompatible microparticle composition comprising a 1,2-benzazole of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof.
Inventor(s): Mesens; Jean (Wechelderzande, BE), Rickey; Michael E. (Loveland, OH), Atkins; Thomas J. (York, PA)
Assignee: Alkermes Controlled Therapeutics Inc. II (Cambridge, MA) Janssen Pharmaceutica (BE)
Application Number:09/252,486
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Formulation;

No matches for this query

International Patent Family for Patent: 6,110,921

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Portugal729357► Subscribe
Romania119224► Subscribe
Slovakia64096► Subscribe
Slovakia282231► Subscribe
Slovenia0729357► Subscribe
Singapore47445► Subscribe
Russian Federation2178695► Subscribe
HungaryT73501► Subscribe
Hungary219487► Subscribe
Israel111647► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKesson
Teva
Fish and Richardson
Federal Trade Commission
Moodys
Medtronic
Cipla
McKinsey
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot